We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A leading Indian pharmaceutical company, Nicholas Piramal Ltd., said Thursday
it has struck a deal to acquire one of Pfizer Inc.'s plants in Britain. Nicholas
Piramal said in a notice to the Bombay Stock Exchange that the acquisition of
the Pfizer facility at Morpeth in northeastern England should boost revenues
by $350 million over the next five years.
